﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2025v4.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2026-01-23T08:20:22-05:00</ReturnTs>
    <TaxPeriodEndDt>2025-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>811705753</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PESANTE CLOSE LLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>POST OFFICE BOX 1877</AddressLine1Txt>
        <CityNm>LA PLATA</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20646</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2025-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>851216725</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>CHONDROSARCOMA CS FOUNDATION INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>CHON</BusinessNameControlTxt>
      <PhoneNum>3013523042</PhoneNum>
      <USAddress>
        <AddressLine1Txt>12504 QUARTERHORSE DRIVE</AddressLine1Txt>
        <CityNm>BOWIE</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20720</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JEFFREY KRAMER</PersonNm>
      <PersonTitleTxt>PRESIDENT</PersonTitleTxt>
      <PhoneNum>3013523042</PhoneNum>
      <SignatureDt>2026-01-20</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>ANNE K WOOD EA</PreparerPersonNm>
      <PTIN>P00749065</PTIN>
      <PhoneNum>3019343399</PhoneNum>
      <PreparationDt>2026-01-23</PreparationDt>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2025</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="3">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc2">
      <PrincipalOfficerNm>JEFFREY KRAMER</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>12504 QUARTERHORSE DR</AddressLine1Txt>
        <CityNm>BOWIE</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20720</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>117233</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>CSFSHAYNA.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationAssocInd>X</TypeOfOrganizationAssocInd>
      <FormationYr>2020</FormationYr>
      <LegalDomicileStateCd>MD</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE PURPOSE OF CS FOUNDATION IS TO EDUCATE THE PUBLIC ABOUT CHONDROSARCOMA; SUPPORT AND ADVOCATE FOR PATIENTS AND FAMILIES THAT ARE SUFFERING FROM THIS DISEASE, AND ADVOCATE TO IMPROVE THE TREATMENT AND CARE FOR THESE PATIENTS. CS FOUNDATION ALSO STRIVES TO ADVOCATE AND PROMOTE POSITIVE CHANGES INCLUDING A VIABLE TREATMENT PROTOCOL, EARLY DETECTION, PROPER SURVEILLANCE, MORE EFFICIENT AND RELEVANT INFORMATION DEDICATED TO CHONDROSARCOMA, AS WELL AS CREATING NETWORKING OPPORTUNITIES FOR SARCOMA EXPERTS TO SPECIFICALLY ADDRESS CHONDROSARCOMA. MOST IMPORTANTLY, CS FOUNDATION STRIVES TO ADVOCATE FOR MORE COMPASSIONATE CARE, CUTTING THROUGH PHARMACEUTICAL RED-TAPE, AND PROMOTING THE PATIENTS RIGHT TO RECEIVE TREATMENT ESPECIALLY IF NEW SOLUTIONS ARE POTENTIALLY LIFE-SAVING.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>8</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>8</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>118843</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>117077</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <CYInvestmentIncomeAmt>26</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>129</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>130</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>118972</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>117233</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>35601</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>35749</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>35601</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>35749</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>83371</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>81484</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>226886</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>308370</TotalAssetsEOYAmt>
      <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>226886</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>308370</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE PURPOSE OF CS FOUNDATION IS TO EDUCATE THE PUBLIC ABOUT CHONDROSARCOMA; SUPPORT AND ADVOCATE FOR PATIENTS AND FAMILIES THAT ARE SUFFERING FROM THIS DISEASE, AND ADVOCATE TO IMPROVE THE TREATMENT AND CARE FOR THESE PATIENTS. CS FOUNDATION ALSO STRIVES TO ADVOCATE AND PROMOTE POSITIVE CHANGES INCLUDING A VIABLE TREATMENT PROTOCOL, EARLY DETECTION, PROPER SURVEILLANCE, MORE EFFICIENT AND RELEVANT INFORMATION DEDICATED TO CHONDROSARCOMA, AS WELL AS CREATING NETWORKING OPPORTUNITIES FOR SARCOMA EXPERTS TO SPECIFICALLY ADDRESS CHONDROSARCOMA. MOST IMPORTANTLY, CS FOUNDATION STRIVES TO ADVOCATE FOR MORE COMPASSIONATE CARE, CUTTING THROUGH PHARMACEUTICAL RED-TAPE, AND PROMOTING THE PATIENTS RIGHT TO RECEIVE TREATMENT ESPECIALLY IF NEW SOLUTIONS ARE POTENTIALLY LIFE-SAVING.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>14537</ExpenseAmt>
      <Desc>THINK TANK CONFERENCE</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>7125</ExpenseAmt>
        <Desc>TUMOR BOARD</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>5000</ExpenseAmt>
        <Desc>PATIENT REGISTRY</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>4589</ExpenseAmt>
        <Desc>OTHER RELATED EVENTS SUCH AS CS AWARENESS DAY, VIRTUAL DIALOGE VIDEOS, POSITION PAPERS,AND HELPFUL BROCHURES</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>4589</TotalOtherProgSrvcExpenseAmt>
      <TotalProgramServiceExpensesAmt>31251</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc3">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd>false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd>false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd>false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd>false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd>false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>false</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>false</BackupWthldComplianceInd>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <GoverningBodyVotingMembersCnt>8</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>8</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>ANNE WOOD</PersonNm>
        <PhoneNum>3013523042</PhoneNum>
        <USAddress>
          <AddressLine1Txt>242 CHESTNUT HLS</AddressLine1Txt>
          <CityNm>HENRICO</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27842</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>KARINA GALOIAN</PersonNm>
        <TitleTxt>VICE PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RONALD KARP</PersonNm>
        <TitleTxt>2ND VICE PRE</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JEFFREY KRAMER</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>20.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NICOLE LOMAX</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNE WOOD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>117077</AllOtherContributionsAmt>
      <TotalContributionsAmt>117077</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>26</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>26</RelatedOrExemptFuncIncomeAmt>
      </InvestmentIncomeGrp>
      <OtherRevenueMiscGrp>
        <Desc>CREDIT CARD REWARDS</Desc>
        <TotalRevenueColumnAmt>130</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>130</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>130</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>117233</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>156</RelatedOrExemptFuncIncomeAmt>
      </TotalRevenueGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>13020</TotalAmt>
        <ProgramServicesAmt>12125</ProgramServicesAmt>
        <ManagementAndGeneralAmt>895</ManagementAndGeneralAmt>
      </FeesForServicesManagementGrp>
      <AdvertisingGrp>
        <TotalAmt>1978</TotalAmt>
        <ProgramServicesAmt>1978</ProgramServicesAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>2855</TotalAmt>
        <ManagementAndGeneralAmt>2855</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>748</TotalAmt>
        <ManagementAndGeneralAmt>748</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>2611</TotalAmt>
        <ProgramServicesAmt>2611</ProgramServicesAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>14537</TotalAmt>
        <ProgramServicesAmt>14537</ProgramServicesAmt>
      </ConferencesMeetingsGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>35749</TotalAmt>
        <ProgramServicesAmt>31251</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4498</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>226886</BOYAmt>
        <EOYAmt>308370</EOYAmt>
      </CashNonInterestBearingGrp>
      <TotalAssetsGrp>
        <BOYAmt>226886</BOYAmt>
        <EOYAmt>308370</EOYAmt>
      </TotalAssetsGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>226886</BOYAmt>
        <EOYAmt>308370</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>226886</BOYAmt>
        <EOYAmt>308370</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>226886</BOYAmt>
        <EOYAmt>308370</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>81484</ReconcilationRevenueExpnssAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc3">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>20986</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>45863</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>106978</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>118843</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>117077</CurrentTaxYearAmt>
        <TotalAmt>409747</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>20986</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>45863</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>106978</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>118843</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>117077</CurrentTaxYearAmt>
        <TotalAmt>409747</TotalAmt>
      </TotalCalendarYear170Grp>
      <PublicSupportTotal170Amt>409747</PublicSupportTotal170Amt>
      <TotalSupportAmt>409747</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>285</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>1.00000</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>1.00000</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleO documentId="RetDoc2">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>THE PURPOSE OF CS FOUNDATION IS TO EDUCATE THE PUBLIC ABOUT CHONDROSARCOMA; SUPPORT AND ADVOCATE FOR PATIENTS AND FAMILIES THAT ARE SUFFERING FROM THIS DISEASE, AND ADVOCATE TO IMPROVE THE TREATMENT AND CARE FOR THESE PATIENTS. CS FOUNDATION ALSO STRIVES TO ADVOCATE AND PROMOTE POSITIVE CHANGES INCLUDING A VIABLE TREATMENT PROTOCOL, EARLY DETECTION, PROPER SURVEILLANCE, MORE EFFICIENT AND RELEVANT INFORMATION DEDICATED TO CHONDROSARCOMA, AS WELL AS CREATING NETWORKING OPPORTUNITIES FOR SARCOMA EXPERTS TO SPECIFICALLY ADDRESS CHONDROSARCOMA. MOST IMPORTANTLY, CS FOUNDATION STRIVES TO ADVOCATE FOR MORE COMPASSIONATE CARE, CUTTING THROUGH PHARMACEUTICAL RED-TAPE, AND PROMOTING THE PATIENTS RIGHT TO RECEIVE TREATMENT ESPECIALLY IF NEW SOLUTIONS ARE POTENTIALLY LIFE-SAVING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 1, PART I, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>COMMITTEE VOLUNTEERS</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4D</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER RELATED EVENTS SUCH AS CS AWARENESS DAY, VIRTUAL DIALOGE VIDEOS, POSITION PAPERS,AND HELPFUL BROCHURES</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>NO REVIEW WAS OR WILL BE CONDUCTED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>NO DOCUMENTS AVAILABLE TO THE PUBLIC</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>